Back to IndieWire

Summit Sets Seth Rogen/Joseph Gordon-Levitt Cancer Comedy, Retitled ’50/50,’ For Sept 30th

Summit Sets Seth Rogen/Joseph Gordon-Levitt Cancer Comedy, Retitled '50/50,' For Sept 30th

Terminal illness and comedy: not always the easiest combination to market. While a film like “Terms of Endearment” was a colossal success, that was a quarter of a century ago, and a more recent example like “Funny People” showed how even the seemingly unstoppable pairing of Judd Apatow and Adam Sandler could come unstuck at the box office when death is on the agenda.

This all goes some way towards explaining why the upcoming cancer-themed comedy-drama produced by and starring Seth Rogen has gone through so many title changes. Originally called “I’m With Cancer,” the script, by real-life cancer survivor Will Reiser, featured highly on the Black List a few years back, and attracted Rogen’s attention. Summit picked the film up, but the name was swiftly jettisoned, with the film briefly being known as “Untitled Cancer Comedy,” and, more recently, “Live With It.”

The film has had its fair share of other problems — original director Nicole Holofcener dropped out, to be replaced byThe Wackness” helmer Jonathan Levine, while James McAvoy, who was set to star, left on the eve of filming, to be replaced at the last minute by Joseph Gordon-Levitt. But things are finally looking up for the project, which also stars Anna Kendrick, Bryce Dallas Howard, Philip Baker Hall and Angelica Huston, with Summit setting a (hopefully final) title, and a release date for the film.

Variety announces that the project is now known as “50/50,” and will hit theaters on September 30th, going up against Roland Emmerich‘s period drama “Anonymous,” Jim Sheridan‘s chiller “Dream House,” with Daniel Craig and Rachel Weisz, and the Anna Faris/Chris Evans rom-com “What’s Your Number.”

It’s certainly a crowded time (and more direct competition hits either side, in the form of Bennett Miller‘s “Moneyball” the week before, and Apatow/David Wain collaboration “Wanderlust” the week after), but it suggests a certain bullishness on Summit’s behalf, particularly as, intriguingly, Variety hints that going in for awards consideration may play a part in the film’s move. We’re certainly curious to see more from the film — we like Levine, the script is well liked, and the cast is very strong. Our guess is that the film will probably end up bowing at TIFF in early September; hopefully we’ll know then if it’s been pulled off.

This Article is related to: Uncategorized and tagged , , , , ,



I saw a test screening of this back in November. While I normally hate dramedies, I felt this was a very successful film. The casting is spot on, and Joseph Gordon-Levitt gives a performance that stayed with me for days.

Also, while “Live With It” was definitely my favorite, “50/50” is a huge step up from the garbage title they were testing at the screening I attended.


Sid, also the directing job- not just the acting.


Wow…terrible title. I liked the first title the most.

Solid script; end product will definitely rely on the performances of the actors.

Your email address will not be published. Required fields are marked *